Publication
Antimigratory and antiproliferative effects of the brain‐targeted peptide conjugate PepH3‐vCPP2319 on triple negative breast cancer cell cultures
dc.contributor.author | Gonçalves, Catarina | |
dc.contributor.author | Castanho, Miguel A. R. B. | |
dc.contributor.author | Cavaco, Marco | |
dc.contributor.author | Neves, Vera | |
dc.date.accessioned | 2025-07-02T13:28:10Z | |
dc.date.available | 2025-07-02T13:28:10Z | |
dc.date.issued | 2025 | |
dc.description | © 2025 European Peptide Society and John Wiley & Sons, Ltd. | pt_PT |
dc.description.abstract | Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype affecting mostly younger women with a poor 5-year overall survival. It is characterized by a high metastization rate, particularly to the brain, where the blood-brain barrier (BBB) hinders the pharmaceuticals delivery. New anticancer drugs able to inhibit cell migration are required to effectively prevent the development of metastasis. PepH3-vCPP2319 (AGILKRW(Ahx)WRRRYRRWRRRRRQRRRPRR-amide), consisting of the conjugation of the BBB peptide shuttle (BBBpS) PepH3 (AGILKRW-amide) to the anticancer peptide (ACP) vCPP2319 (WRRRYRRWRRRRRQRRRPRR-amide), was reported to have high anticancer activity (IC50 = 5.0 μM) toward highly aggressive TNBC cells (MDA-MB-231) paired with 2-fold increased accumulation in the brain when compared to unconjugated vCPP2319. Herein, we demonstrate that PepH3-vCPP2319 inhibits cell migration and proliferation in wound healing assays, outperforming the gold standard small chemical inhibitor, iCRT-3. The concentration required to inhibit cell migration is 10-fold lower for PepH3-vCPP2319 (0.5 μM) when compared with iCRT-3 (50 μM). Likewise, PepH3-vCPP2319 at 2.5 μM was more efficient in preventing cell proliferation when compared with 50 μM iCRT-3, with 45% reduction in spheroid diameter. This study sheds light on the antimetastatic potential of PepH3-vCPP2319 through abrogation of cell migration to distant sites, including the brain. | pt_PT |
dc.description.sponsorship | The project leading to these results has received funding from “la Caixa” Foundation (ID 100010434) and FCT, I. P under the agreement LCF/ PR/HP21/52310015 and “Fundação para a Ciência e Tecnologia” (FCT, Portugal) (grant: 2021.00895.CEECIND, PD/BD/128281/2017, PTDC/QUI- OUT/3854/2021; 2023.12099.PEX). We also acknowledge FCT for the PhD scholarship—UI/BD/151171/2021 | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | J Pept Sci. 2025 Aug;31(8):e70035 | pt_PT |
dc.identifier.doi | 10.1002/psc.70035 | pt_PT |
dc.identifier.eissn | 1099-1387 | |
dc.identifier.issn | 1075-2617 | |
dc.identifier.uri | http://hdl.handle.net/10400.5/101973 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Wiley | pt_PT |
dc.relation | LCF/PR/HP21/52310015 | pt_PT |
dc.relation | Diagnostic tool for Alzheimer’s disease based on a proprietary blood-brain barrier peptide shuttle-nanoparticle | |
dc.relation | PPBI-POCI-01-0145-FEDER-022122 | pt_PT |
dc.relation.publisherversion | https://onlinelibrary.wiley.com/journal/10991387 | pt_PT |
dc.subject | Anticancer peptides | pt_PT |
dc.subject | Cancer metastasis | pt_PT |
dc.subject | Cancer stem cells | pt_PT |
dc.subject | Cell migration | pt_PT |
dc.subject | Triple negative breast cancer | pt_PT |
dc.title | Antimigratory and antiproliferative effects of the brain‐targeted peptide conjugate PepH3‐vCPP2319 on triple negative breast cancer cell cultures | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.awardTitle | Diagnostic tool for Alzheimer’s disease based on a proprietary blood-brain barrier peptide shuttle-nanoparticle | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/CEEC IND4ed/2021.00895.CEECIND%2FCP1673%2FCT0004/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/OE/PD%2FBD%2F128281%2F2017/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FQUI-OUT%2F3854%2F2021/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/Concurso de Projetos Exploratórios em Todos os Domínios Científicos 2023/2023.12099.PEX/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT//UI%2FBD%2F151171%2F2021/PT | |
oaire.citation.issue | 8 | pt_PT |
oaire.citation.title | Journal of Peptide Science | pt_PT |
oaire.citation.volume | 31 | pt_PT |
oaire.fundingStream | CEEC IND4ed | |
oaire.fundingStream | OE | |
oaire.fundingStream | 3599-PPCDT | |
oaire.fundingStream | Concurso de Projetos Exploratórios em Todos os Domínios Científicos 2023 | |
person.familyName | Castanho | |
person.familyName | Cavaco | |
person.familyName | Neves | |
person.givenName | Miguel | |
person.givenName | Marco | |
person.givenName | Vera | |
person.identifier | 1069324 | |
person.identifier | 953259 | |
person.identifier.ciencia-id | 1412-63B8-7494 | |
person.identifier.ciencia-id | 671C-1860-A160 | |
person.identifier.orcid | 0000-0001-7891-7562 | |
person.identifier.orcid | 0000-0002-0938-9038 | |
person.identifier.orcid | 0000-0002-2989-7208 | |
person.identifier.rid | O-2176-2018 | |
person.identifier.scopus-author-id | 56605575600 | |
person.identifier.scopus-author-id | 26537945300 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
rcaap.rights | restrictedAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | f5e46f85-fabf-450a-9ee2-1c7b59410892 | |
relation.isAuthorOfPublication | ce7bbed1-4210-464f-93ac-f270ca7d2140 | |
relation.isAuthorOfPublication | f62bb731-3f4d-4eaf-bc6b-dd379f6c2327 | |
relation.isAuthorOfPublication.latestForDiscovery | f5e46f85-fabf-450a-9ee2-1c7b59410892 | |
relation.isProjectOfPublication | 4ef997e7-5b46-4515-a883-5e994d347326 | |
relation.isProjectOfPublication | e5480eb7-9226-46b4-abc7-4aca054feb12 | |
relation.isProjectOfPublication | 204a5c02-d515-4a8e-b1d5-7bec527c5cd5 | |
relation.isProjectOfPublication | 365dc336-956f-4ebd-aade-c572fe8ad5f9 | |
relation.isProjectOfPublication | 5389c5ec-9e3f-4541-8171-574e76137971 | |
relation.isProjectOfPublication.latestForDiscovery | 4ef997e7-5b46-4515-a883-5e994d347326 |